Muscarinic Receptors in Psychiatric Disorders – Can We Mimic ‘Health’?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neurosignals

• Publication date

  2009-05-05

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1159/000231896PMID 19816066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allosteric Modulation of Muscarinic Acetylcholine Receptors

  2010cited by this paper
• Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice

  2009cited by this paper
• Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity

  2009cited by this paper
• Mutagenic Mapping Suggests a Novel Binding Mode for Selective Agonists of M1 Muscarinic Acetylcholine Receptors

  2009cited by this paper
• Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.

  2009cited by this paper
• Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia

  2009cited by this paper
• Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders.

  2009cited by this paper
• Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice.

  2009cited by this paper
• Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia

  2008cited by this paper
• Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia?

  2008cited by this paper
• Muscarinic acetylcholine receptors in macaque V1 are most frequently expressed by parvalbumin‐immunoreactive neurons

  2008cited by this paper
• Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77‐LH‐28‐1

  2008cited by this paper
• Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine.

  2008cited by this paper
• Muscarinic acetylcholine receptors as CNS drug targets.

  2008cited by this paper
• Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1.

  2008cited by this paper
• Antipsychotic-like behavioral effects and cognitive enhancement by a potent and selective muscarinic M-sub-1 receptor agonist, AC-260584.

  2008cited by this paper
• Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia.

  2008cited by this paper
• G Protein Coupling and Signaling Pathway Activation by M1 Muscarinic Acetylcholine Receptor Orthosteric and Allosteric Agonists

  2008cited by this paper
• Neuronal nicotinic acetylcholine receptors: from the genetic analysis to neurological diseases.

  2008cited by this paper
• Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats

  2008cited by this paper
• Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats

  2008cited by this paper
• An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission.

  2008cited by this paper
• Towards a muscarinic hypothesis of schizophrenia

  2007cited by this paper
• Altered hippocampal muscarinic M4, but not M1, receptor expression from subjects with schizophrenia.

  2007cited by this paper
• Muscarinic Control of Long-Range GABAergic Inhibition within the Rhinal Cortices

  2007cited by this paper
• AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus.

  2007cited by this paper
• Muscarinic M 2 and M 1 Receptors Reduce GABA Release by Ca 2 Channel Modulation Through Activation of PI 3 K / Ca 2-Independent and PLC / Ca 2-Dependent PKC

  2007cited by this paper
• Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.

  2007cited by this paper
• Muscarinic M2 and M1 receptors reduce GABA release by Ca2+ channel modulation through activation of PI3K/Ca2+ -independent and PLC/Ca2+ -dependent PKC.

  2007cited by this paper
• Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial.

  2006cited by this paper
• No change in cortical muscarinic M2, M3 receptors or [35S]GTPgammaS binding in schizophrenia.

  2006cited by this paper
• Structural Requirements of Transmembrane Domain 3 for Activation by the M1 Muscarinic Receptor Agonists AC-42, AC-260584, Clozapine, and N-Desmethylclozapine: Evidence for Three Distinct Modes of Receptor Activation

  2006cited by this paper
• Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder.

  2006cited by this paper
• Modulation of synaptic plasticity by physiological activation of M[1] muscarinic acetylcholine receptors in the mouse hippocampus

  2006cited by this paper
• Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist

  2006cited by this paper
• Simultaneous Release of Glutamate and Acetylcholine from Single Magnocellular “Cholinergic” Basal Forebrain Neurons

  2006cited by this paper
• Modulation of Synaptic Plasticity by Physiological Activation of M1 Muscarinic Acetylcholine Receptors in the Mouse Hippocampus

  2005cited by this paper
• The pharmacological action of MT-7.

  2005cited by this paper
• Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia

  2005cited by this paper
• Acetylcholine modulates cortical synaptic transmission via different muscarinic receptors, as studied with receptor knockout mice

  2005cited by this paper
• M2/M4 muscarinic receptor binding in the anterior cingulate cortex in schizophrenia and mood disorders.

  2005cited by this paper
• Event-related gamma activity in schizophrenia patients during a visual backward-masking task.

  2005cited by this paper
• Muscarinic Acetylcholine Receptor Knockout Mice

  2004cited by this paper
• Investigation of M1/M4 Muscarinic Receptors in the Anterior Cingulate Cortex in Schizophrenia, Bipolar Disorder, and Major Depression Disorder

  2004cited by this paper
• M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related central nervous system pathologies

  2004cited by this paper
• Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

  2004cited by this paper
• The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine

  2004cited by this paper
• A comparison of M1 and M4 muscarinic receptors in the thalamus from control subjects and subjects with schizophrenia

  2004cited by this paper
• Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.

  2004cited by this paper
• Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

  2004cited by this paper
• The cholinergic innervation of the human cerebral cortex.

  2004cited by this paper
• Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice

  2003cited by this paper
• Regulation of muscarinic acetylcholine receptor signaling.

  2003cited by this paper
• M1-M5 muscarinic receptor knockout mice as novel tools to study the physiological roles of the muscarinic cholinergic system.

  2003cited by this paper
• Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

  2003cited by this paper
• In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia.

  2003cited by this paper
• Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine‐induced seizure activity

  2003cited by this paper
• Reduced expression of the muscarinic 1 receptor cortical subtype in schizophrenia

  2003cited by this paper
• Cholinergic modulation of the cortical neuronal network

  2003cited by this paper
• Muscarinic receptors as a target for drugs treating schizophrenia.

  2002cited by this paper
• Muscarinic induction of hippocampal gamma oscillations requires coupling of the M1 receptor to two mixed cation currents.

  2002cited by this paper
• Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia

  2002cited by this paper
• Discovery of an ectopic activation site on the M(1) muscarinic receptor.

  2002cited by this paper
• Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia

  2002cited by this paper
• Characterization of Central Inhibitory Muscarinic Autoreceptors by the Use of Muscarinic Acetylcholine Receptor Knock-Out Mice

  2002cited by this paper
• Aminergic receptors in astrogliotic plaques from patients with multiple sclerosis.

  2002cited by this paper
• Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean

  2001cited by this paper
• Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents implications for cholinergic involvement in parkinsonism.

  2001cited by this paper
• Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice

  2001cited by this paper
• Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.

  2001cited by this paper
• The M3 Muscarinic Acetylcholine Receptor Expressed in HEK-293 Cells Signals to Phospholipase D via G12 but Not Gq-type G Proteins

  2001cited by this paper
• Gq/11 and Gi/o activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor‐subtype

  2001cited by this paper
• Hyperactivity and Intact Hippocampus-Dependent Learning in Mice Lacking the M1 Muscarinic Acetylcholine Receptor

  2001cited by this paper
• Hippocampal Astrocytes Exhibit Ca2+ ‐Elevating Muscarinic Cholinergic and Histaminergic Receptors In Situ

  2000cited by this paper
• Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.

  2000cited by this paper
• Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia.

  1999cited by this paper
• The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia.

  1999cited by this paper
• Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland.

  1999cited by this paper
• Acetylcholine in mind: a neurotransmitter correlate of consciousness?

  1999cited by this paper
• The neuropathology of schizophrenia. A critical review of the data and their interpretation.

  1999cited by this paper
• THE CHOLINERGIC ‘PITFALL’: ACETYLCHOLINE, A UNIVERSAL CELL MOLECULE IN BIOLOGICAL SYSTEMS, INCLUDING HUMANS

  1999cited by this paper
• Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice.

  1999cited by this paper
• Pleiotropic Behavior of 5‐HT2A and 5‐HT2C Receptor Agonists

  1998cited by this paper
• Localization of the m2 muscarinic acetylcholine receptor protein and mRNA in cortical neurons of the normal and cholinergically deafferented rhesus monkey

  1998cited by this paper
• Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells.

  1998cited by this paper
• Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.

  1998cited by this paper
• Functional effects of the muscarinic receptor agonist, xanomeline, at 5‐HT1 and 5‐HT2 receptors

  1998cited by this paper
• International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

  1998cited by this paper
• Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.

  1997cited by this paper
• Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease

  1997cited by this paper
• Behavioural evaluation of cholinergic drugs.

  1997cited by this paper
• S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.

  1997cited by this paper
• M1 Agonists for the Treatment of Alzheimer's Disease.

  1996cited by this paper
• The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia.

  1996cited by this paper
• Increased pupillary sensitivity to pilocarpine in depression.

  1996cited by this paper
• Molecular biology of muscarinic acetylcholine receptors.

  1996cited by this paper
• Differential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease

  1995cited by this paper
• Allosteric modulation of muscarinic acetylcholine receptors.

  1995cited by this paper
• Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission.

  1993cited by this paper
• Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.

  1992cited by this paper

• Xanomeline-Trospium Chloride as a New Paradigm in the Treatment of Schizophrenia Through Muscarinic Modulation: A Renewed Hope in Psychiatric Care.

  2026cites this paper
• Muscarinic Receptors and Alzheimer’s Disease: New Perspectives and Mechanisms

  2024cites this paper
• Clinical Effectiveness of Muscarinic Receptor-Targeted Interventions in Neuropsychiatric Disorders: A Systematic Review

  2022cites this paper
• Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders

  2022cites this paper
• Disrupted hemispheric connectivity specialization in patients with major depressive disorder: Evidence from the REST-meta-MDD Project.

  2021cites this paper
• Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis

  2020cites this paper
• Similar, or dissimilar, that is the question. How different are methods for comparison of compounds similarity?

  2020cites this paper
• Nicotine abolishes memory‐related synaptic strengthening and promotes synaptic depression in the neurogenic dentate gyrus of miR‐132/212 knockout mice

  2020cites this paper
• More optimal but less regulated dorsal and ventral visual networks in patients with major depressive disorder.

  2019cites this paper
• Repeated bifenthrin exposure alters hippocampal Nurr-1/AChE and induces depression-like behavior in adult rats.

  2019cites this paper
• Functional coupling of M1 muscarinic acetylcholine receptor to Gαq/11 in dorsolateral prefrontal cortex from patients with psychiatric disorders: a postmortem study

  2019cites this paper
• Effect of Perampanel or Amantadine Treatment on Pilocarpine Rat Model of Status Epilepticus: Evidence with Seizure Termination, Behavioral Alterations, Epileptogenesis and Neuronal Damage.

  2018cites this paper
• α7 Nicotinic acetylcholine receptor-mediated anti-inflammatory actions modulate brain functions

  2016cites this paper
• Potential targets for the development of novel antidepressants: future perspectives.

  2015cites this paper
• The Impact of Kolaviron (A Bioflavonoid of Garcinia Kola Seed) On Depression Status in Laboratory Rodents: Roles of Monoaminergic Systems

  2015cites this paper
• Is methoxydine a new rapid acting antidepressant for the treatment of depression in alcoholics?

  2013cites this paper
• Cholinergic muscarinic receptors: new opportunities to treat psychiatric disorders.

  2013cites this paper
• The Development of Neurodegeneration and Behavioural Alterations following Lithium/Pilocarpine-induced Status Epilepticus in Rats

  2013influential citation
• Overview of muscarinic receptor subtypes.

  2012cites this paper
• Coincidence Signaling of Dopamine D1-Like and M1 Muscarinic Receptors in the Regulation of Cyclic AMP Formation and CREB Phosphorylation in Mouse Prefrontal Cortex

  2012cites this paper
• Muscarinic acetylcholine receptor-mediated activation of Gq in rat brain membranes determined by guanosine-5′-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding using an anti-G protein scintillation proximity assay

  2012cites this paper
• eview ey players in major and bipolar depression — A retrospective analysis of in vivo maging studies

  2012cites this paper
• Methoxetamine: from drug of abuse to rapid-acting antidepressant.

  2012cites this paper
• Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe

  2012cites this paper
• Behavioral and pharmacological assessment of a potential new mouse model for mania.

  2011cites this paper
• ‘Pseudo-paraplegia': a chronic psychotic sequela of organophosphate exposure in schizophrenia

  2011cites this paper
• The cholinergic system and depression.

  2011cites this paper
• Novel Strains of Mice Deficient for the Vesicular Acetylcholine Transporter: Insights on Transcriptional Regulation and Control of Locomotor Behavior

  2011cites this paper
• Clinical Management of Atopic Eczema with Pimecrolimus Cream 1% (Elidel®) in Paediatric Patients

  2007cites this paper
• University of Groningen The stressed brain

  year unknowncites this paper